Assignee
NEKTAR THERAPEUTICS AL CORP
US·44 granted patents·5 pending applications·1,862 citations·filing 2001–2010
Top patents by PatentIndex Score
49 records- 0199US7259224B2Hydrolytically degradable polymers and hydrogels made therefromNEKTAR THERAPEUTICS AL CORP·Filed 2006·Granted Aug 21, 2007·40 cites·1 claims
- 0299US7199223B2Polymer-factor VIII moiety conjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2004·Granted Apr 3, 2007·177 cites·31 claims
- 0398US7405266B2Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereofNEKTAR THERAPEUTICS AL CORP·Filed 2007·Granted Jul 29, 2008·43 cites·13 claims
- 0498US7223803B2Polyethylene (glycol) derivatives with proximal reactive groupsNEKTAR THERAPEUTICS AL CORP·Filed 2005·Granted May 29, 2007·24 cites·24 claims
- 0598US7026440B2Branched polymers and their conjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Apr 11, 2006·109 cites·35 claims
- 0698US6864350B2Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solutionNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Mar 8, 2005·64 cites·44 claims
- 0798US6838528B2Multi-arm block copolymers as drug delivery vehiclesNEKTAR THERAPEUTICS AL CORP·Filed 2004·Granted Jan 4, 2005·114 cites·38 claims
- 0898US6774180B2Synthesis of high molecular weight non-peptidic polymer derivativesNEKTAR THERAPEUTICS AL CORP·Filed 2001·Granted Aug 10, 2004·96 cites·45 claims
- 0998US6737505B2Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereofNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted May 18, 2004·179 cites·36 claims
- 1098US6664331B2Poly(ethylene glycol) derivatives with proximal reactive groupsNEKTAR THERAPEUTICS AL CORP·Filed 2001·Granted Dec 16, 2003·98 cites·53 claims
- 1197US7528202B2Poly (ethylene glycol) derivatives with proximal reactive groupsNEKTAR THERAPEUTICS AL CORP·Filed 2007·Granted May 5, 2009·17 cites·22 claims
- 1297US7432331B2Hydrolytically stable maleimide-terminated polymersNEKTAR THERAPEUTICS AL CORP·Filed 2005·Granted Oct 7, 2008·25 cites·40 claims
- 1397US7060259B2Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)NEKTAR THERAPEUTICS AL CORP·Filed 2005·Granted Jun 13, 2006·33 cites·28 claims
- 1497US6894025B2Biologically active molecules having thiol moiety conjugated to polymers containing ethyl sulfone moietyNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted May 17, 2005·55 cites·12 claims
- 1597US6730334B2Multi-arm block copolymers as drug delivery vehiclesNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted May 4, 2004·69 cites·96 claims
- 1696US7511094B2Water-soluble polymer alkanalsNEKTAR THERAPEUTICS AL CORP·Filed 2006·Granted Mar 31, 2009·16 cites·40 claims
- 1796US7053150B2Segmented polymers and their conjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted May 30, 2006·81 cites·48 claims
- 1896US6710125B2Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)NEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Mar 23, 2004·43 cites·13 claims
- 1995US7589157B2Multi-arm block copolymers as drug delivery vehiclesNEKTAR THERAPEUTICS AL CORP·Filed 2007·Granted Sep 15, 2009·11 cites·11 claims
- 2095US7378469B2Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)NEKTAR THERAPEUTICS AL CORP·Filed 2006·Granted May 27, 2008·19 cites·25 claims
- 2195US7205380B2Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereofNEKTAR THERAPEUTICS AL CORP·Filed 2005·Granted Apr 17, 2007·12 cites·26 claims
- 2295US7056500B2Polymer conjugates of opioid antagonistsNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Jun 6, 2006·58 cites·19 claims
- 2395US6911197B2N-maleimidyl polymer derivativesNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Jun 28, 2005·32 cites·42 claims
- 2495US6908963B2Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS AL CORP·Filed 2001·Granted Jun 21, 2005·39 cites·32 claims
- 2594US7511095B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS AL CORP·Filed 2006·Granted Mar 31, 2009·12 cites·19 claims
- 2694US7078496B2Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewithNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Jul 18, 2006·36 cites·43 claims
- 2793US7316811B2Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehiclesNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Jan 8, 2008·45 cites·29 claims
- 2893US7157546B2Water-soluble polymer alkanalsNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Jan 2, 2007·29 cites·78 claims
- 2992US7329721B2Maleamic acid polymer derivatives and their bioconjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Feb 12, 2008·36 cites·37 claims
- 3092US7265186B2Multi-arm block copolymers as drug delivery vehiclesNEKTAR THERAPEUTICS AL CORP·Filed 2004·Granted Sep 4, 2007·37 cites·48 claims
- 3191US7579444B2Polymer-factor IX moiety conjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2005·Granted Aug 25, 2009·14 cites·18 claims
- 3291US7544738B2Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)NEKTAR THERAPEUTICS AL CORP·Filed 2008·Granted Jun 9, 2009·8 cites·3 claims
- 3391US7030278B2Polyethylene(Glycol) derivatives with proximal reactive groupsNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Apr 18, 2006·19 cites·26 claims
- 3491US6899867B2Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)NEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted May 31, 2005·23 cites·48 claims
- 3590US7432330B2Hydrolytically stable maleimide-terminated polymersNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Oct 7, 2008·29 cites·61 claims
- 3690US6864327B2Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparationNEKTAR THERAPEUTICS AL CORP·Filed 2002·Granted Mar 8, 2005·28 cites·21 claims
- 3789US7101932B2Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)NEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Sep 5, 2006·14 cites·39 claims
- 3889US6992168B2Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereofNEKTAR THERAPEUTICS AL CORP·Filed 2004·Granted Jan 31, 2006·17 cites·24 claims
- 3988US7312301B2Methods for the formation of hydrogels using thiosulfonate compositions and uses thereofNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Dec 25, 2007·18 cites·12 claims
- 4086US7569214B2Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acidNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Aug 4, 2009·15 cites·19 claims
- 4184US7419600B2Method for purifying a branched water-soluble polymerNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Sep 2, 2008·12 cites·20 claims
- 4281US7214366B2Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and moleculesNEKTAR THERAPEUTICS AL CORP·Filed 2005·Granted May 8, 2007·2 cites·20 claims
- 4378US7208145B2Polymeric reagents comprising a ketone or a related functional groupNEKTAR THERAPEUTICS AL CORP·Filed 2003·Granted Apr 24, 2007·14 cites·12 claims
- 4468US2009280550A1Polymer-Factor IX Moiety ConjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2009·Application pending·0 cites
- 4564US2008194612A1Multi-arm polymer prodrugsNEKTAR THERAPEUTICS AL CORP·Filed 2008·Application pending·0 cites
- 4660US2011009589A1Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefromNEKTAR THERAPEUTICS AL CORP·Filed 2010·Application pending·0 cites
- 4755US7547509B2Cyanovirin variant-polymer conjugatesNEKTAR THERAPEUTICS AL CORP·Filed 2007·Granted Jun 16, 2009·0 cites·10 claims
- 4849US2010284960A1Dosage Forms and Co-Administration of Opioid Agonist and Opioid AntagonistNEKTAR THERAPEUTICS AL CORP·Filed 2007·Application pending·0 cites
- 4944US2006239961A1Hydrolytically degradable alkylene oxide based polymersNEKTAR THERAPEUTICS AL CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEKTAR THERAPEUTICS AL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →